What is Galera Therapeutics (GrTx) stock price?

Galera Therapeutics, Inc.'s stock symbol is GRTX and currently trades under NASDAQ. It’s current price per share is approximately $0.19. People who follow Galera Therapeutics, Inc. (GRTX) also follow INZY, GLTO, HOOK, EYEN. . A high-level overview of Galera Therapeutics, Inc. (GRTX) stock.

Is Galera Therapeutics a good stock to buy?

The company's average rating score is 1.75, and is based on no buy ratings, 3 hold ratings, and 1 sell rating. According to analysts' consensus price target of $7.75, Galera Therapeutics has a forecasted upside of 3,327.7% from its current price of $0.23. Galera Therapeutics has only been the subject of 4 research reports in the past 90 days.

Who owns Galera Therapeutics Inc?

It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA. GRTX | Complete Galera Therapeutics Inc. stock news by MarketWatch.